Table 3.
Symptomatic improvement of the patient
| Non-CSAEs (N=2664) | CSAEs (N=165) | ||
|---|---|---|---|
| N (%) | N (%) | p Value | |
| Much improvement (>90%) | |||
| No | 2048 (76.9) | 134 (81.2) | 0.234† |
| Yes | 616 (23.1) | 31 (18.8) | |
| Improvement (70–90%) | |||
| No | 2344 (88.0) | 144 (87.3) | 0.880† |
| Yes | 320 (12.0) | 21 (12.7) | |
| Moderate improvement (50–70%) | |||
| No | 1555 (58.4) | 100 (60.6) | 0.628† |
| Yes | 1109 (41.6) | 65 (39.4) | |
| Slight improvement (30–50%) | |||
| No | 2320 (87.1) | 142 (86.1) | 0.794† |
| Yes | 344 (12.9) | 23 (13.9) | |
| Little improvement (10–30%) | |||
| No | 2566 (96.3) | 156 (94.5) | 0.342† |
| Yes | 98 (3.7) | 9 (5.5) | |
| No improvement (<10%)or deterioration | |||
| No | 2487 (93.4) | 149 (90.3) | 0.177† |
| Yes | 177 (6.6) | 16 (9.7) | |
χ2 test.
†
Yates' correction for continuity.